Author:
Pinato D J,Ramachandran R,Toussi S T K,Vergine M,Ngo N,Sharma R,Lloyd T,Meeran K,Palazzo F,Martin N,Khoo B,Dina R,Tan T M
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Agarwal A, Mehrotra PK, Jain M, Gupta SK, Mishra A, Chand G, Agarwal G, Verma AK, Mishra SK, Singh U (2010) Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy? World J Surg 34 (12): 3022–3028
2. Ahlman H (2006) Malignant pheochromocytoma: state of the field with future projections. Ann NY Acad Sci 1073: 449–464
3. Allibhai Z, Rodrigues G, Brecevic E, Neumann HP, Winquist E (2004) Malignant pheochromocytoma associated with germline mutation of the SDHB gene. J Urol 172 (4 Pt 1): 1409–1410
4. Blank A, Schmitt AM, Korpershoek E, van Nederveen F, Rudolph T, Weber N, Strebel RT, de Krijger R, Komminoth P, Perren A (2010) SDHB loss predicts malignancy in pheochromocytomas/sympathethic paragangliomas, but not through hypoxia signalling. Endocr Relat Cancer 17 (4): 919–928
5. Bowman A, Gabra H, Langdon SP, Lessells A, Stewart M, Young A, Smyth JF (2002) CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroup. Clin Cancer Resh 8 (7): 2233–2239
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献